What You Should Know: – PathAI has secured a historic regulatory milestone with the FDA qualification of its AIM-MASH AI Assist tool, making it the first AI-powered pathology biomarker to receive such status under the FDA’s Drug Development Tool (DDT) program. This follows a similar qualification from the European Medicines Agency (EMA) earlier this year, […]
